This is a tool to identify specific Alzheimer’s clinical trials. Just click on the start button and enter the information as prompted. You will be provided with a list of the trials within your geographic area.

Seeking caregivers for participation in survey regarding financial exploitation

Are you a caregiver to a patient with a neurodegenerative condition? You are invited to participate in a survey examining the prevalence of financial exploitation and scams in those with neurodegenerative conditions such as dementia. This is a survey study

  • Survey can be completed online or via telephone
  • Estimated completion time = ~20 minutes
  • All analysis will be conducted at the group level

If interested, please contact: Preeti Sunderaraman, PhD at

IRB-AAAT1976 (Y01M00) IRB Exemption Date: 09/03/2020

Take part in our clinical study

The LUCIDITY study is sponsored by TauRx Therapeutics Ltd., a leader in neurodegenerative disease research. As you may be aware, there is an urgent need for better treatments for Alzheimer’s disease (AD) as current therapies help with the symptoms of AD but do not stop the disease from progressing.

If you or a loved one are experiencing memory loss, or have been diagnosed with Mild Cognitive Impairment (MCI or MCI-AD), Probable/Early Alzheimer’s disease, or Mild-Moderate Alzheimer's disease, you or a loved one may be eligible to participate in our clinical research study.

Learn more  Pre-Qualify

Clinical Trial Sites in New York City

These Alzheimer’s clinical trial sites in New York City welcome individuals with memory issues to make an appointment for evaluation. After screening and initial testing, for qualifying candidates the site will suggest appropriate trials for consideration.

Columbia University Medical Center/Taub Institute
710 West 168 Street, 3rd Floor
New York, NY 10032
Phone: 212-305-1818
View Full List
NYU School of Medicine; Center for Cognitive Neurology
145 East 32nd Street
New York, NY 10016
Phone: 212-263-3257
View Full List
Mt Sinai: Icahn School of Medicine
One Gustave L. Levy Place
Box 1230
New York, NY 10029
Phone: 212-241-8329

James J. Peters VA Medical Center
130 West Kingsbridge Road
Bronx, NY 10468
Phone: 718-584-9000 ext. 5199
View Full List
Weill Cornell Medicine
1305 York Avenue; Box 305
New York, NY 10065
Phone: 646-962-8215
View Full List

Montefiore Hudson Valley Center for Excellence for Alzheimer’s Disease
111E 210th Street
Bronx, NY 10467
Phone: 914.375.4880
View full list

Other Research Trials in New York City

NYU Langone Health

The NYU Langone Vaccine Center is seeking healthy adult volunteers who are interested in participating in clinical research for a COVID-19 vaccine study.

For more information, call 646-501-9854 or email:

LEAF: Life Enhancing Activities for Family Caregivers

Do you care for someone with Alzheimer's Disease?
Many family caregivers of people with Alzheimer's Disease experience physical and emotional changes as a result of their caregiving.  Research shows that increasing one’s levels of positive emotion can lower stress and increase the ability to cope with existing stress. We are interested in the effects of applying these techniques with Alzheimer's family caregivers.

Who is eligible to participate?
If you are the primary caregiver of a person diagnosed with Alzheimer's Disease
and have access to a reliable Wi-Fi internet connection, you may be eligible!

Participating in the LEAF study involves:
Taking part in a positive emotions building study program via:

  • Six (6) weekly hour-long video sessions with a facilitator OR a
    6-week self-guided online program (you would be randomly chosen for video sessions or the online program)
  • Nightly home practice to reinforce the skills
  • Online surveys

Visit us at: and fill out our eligibility survey
Email us at:
Call us at: 312-503-5247 (Central time)

New Clinical Study Currently Enrolling People with Memory Loss and Elevated Blood Sugar

The Elevage study (NCT03980730) is being conducted to evaluate the efficacy and safety of azeliragon in patients who are experiencing memory loss and have elevated blood sugar or Type 2 Diabetes.

To qualify for participation in the study you must:

  • Be 50-85 years of age (inclusive)
  • Currently be taking medication for memory loss (including Aricept (donepezil), Exelon (rivastigmine), Razadyne or Reminyl (galantamine) and/or Namenda or Ebixa (memantine), etc.)
  • Have elevated blood sugar (A1c 6.5% to 9.5%)
  • Have a reliable caregiver/study partner

To learn more, click here.

Join a Research Study: Neurodegeneration-Associated Psychiatric Syndromes

Principal Investigator: Edward Huey, M.D.
Seeking participants for an observational research study looking at how dementias (like Alzheimer’s disease) can affect mood and behavior.

  • Participation involves coming in with a study partner (someone who knows you well) for one voluntary, 4-5 hour visit to answer questions about recent mood and emotions and complete an MRI scan
  • Participants will be compensated $50-$100

This study is recruiting participants with dementia, including:

  • People who have been diagnosed with Alzheimer’s disease
  • Who are between 40-90 years old,
  • And who speak English or Spanish.

How do I participate?
If you are interested in becoming involved in this study or learning more, please contact the research team at (212) 305-3187 or

Weill Cornell Medicine - Family Caregiver Research Study

Do you care for someone with dementia and pain? Are you a family member or unpaid caregiver?

If so, we want to learn from you! You are invited to participate in a one-time, 20-30 minute in person or phone interview. To thank you for your time, you will be provided with a $15 gift card after completing the interview.

For more information or to participate, please contact Dr. Riffin: 212-746-7317 or

Care Partners Program

If you are caring for a loved one with Alzheimer’s or other dementias, you might be eligible to take part in a research study that Weill Cornell Medicine is conducting. You will learn strategies to reduce stress, enhance caregiving skills, and improve overall well-being. Your loved one will receive cognitive training or mental stimulating exercises.

The study has a duration of 12 months. You and your loved one can participate from the comfort of your home at no cost. You will receive a laptop with Wi-fi capability during study participation to access study-related material and content. You will also receive financial compensation for your time and effort.

For more information, please contact us at:
(646) 962-7141 or

Seeking individuals with Alzheimer’s disease who experience agitation

The Escitalopram for Agitation in Alzheimer’s Disease (S-CitAD) study is a 12-week trial of escitalopram taking place at Memory Disorders Clinic at New York State Psychiatric Institute.

The S-CitAD Research Study is looking for volunteers who:

  • Have been diagnosed with Alzheimer’s disease
  • Experience feelings of irritability, restlessness, frustration, or anger
  • Have a study partner who can participate in the study

All participants receive: Free parking at each visit, Psychosocial counseling provided to all eligible participants, All visit procedures administered at no cost.

Call 646-774-8671 for more information.

Survey for Caregivers

Are you currently providing care to someone with dementia? Are you employed or were you employed at any point while caring for your friend, family member, or neighbor with Alzheimer’s disease or Dementia? If you answered ‘yes’, then we would love to hear from you!

Researchers at the University at Albany School of Public Health are looking for interested individuals to participate in a study that seeks to understand the experiences of working caregivers. This anonymous survey should take about 10-15 minutes of your time, and can be accessed at the following link:

Participate in a research project on Alzheimer's and Caregiving

The purpose of this project is to identity the types of decisions that caregivers face as their family member or friend progresses through the stages of Alzheimer's.

Learn more

Cognite Early Stage Alzheimer's Clinical Trial

Imagine making an impact

Consider taking part in a clinical trial that is currently enrolling to treat for early stage Alzheimer’s disease

What is the Cognite Trial?

The Cognite Alzheimer’s Clinical Trial is enrolling men and women who have signs of early stage Alzheimer’s disease. The clinical trial is evaluating whether an investigational combined treatment slows down, arrests, or reverses early stage Alzheimer’s disease.

To qualify, participants must:

  • Be between 55 and 79 years old
  • Have at least 8 years of education
  • Have noticed, or have had a loved one notice, changes in your memory
  • Have noticed changes in their normal, everyday behavior
  • Attend all study visits with a study partner with whom the
    participant has frequent contact
  • Be in good general health

Are you or someone you know experiencing memory loss? Are you or someone you know having trouble retaining information? This may be an indication of early stage Alzheimer’s disease, which is a type of dementia that causes problems with an individual’s memory, thinking, and behavior.

For more information:

646-678-4196 |

Learn more (PDF)

Treatment of Psychosis and Agitation in Alzheimer’s Disease

This research study, funded by the NIH, involves a 12-week double-blind treatment trial in which outpatients with Alzheimer’s disease (age 55-95 years) who have agitation/aggression with or without psychosis (hallucinations or delusions) will receive either low-dose lithium or placebo. Patients are allowed to receive other specific psychiatric medications if needed during the study, and will be closely monitored by physicians who specialize in memory disorders. Patients will receive open treatment with lithium, if clinically indicated, after completing the 12-week double blind trial.
For more information, please contact Jesse Strickler at (646) 774-8668 or Identifier: NCT02129348